GLP-1 pills are coming, and they could revolutionize weight-loss treatment
At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...
This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments
It's currently dominated by a few big names in Eli Lilly and Novo Nordisk, but that can change drastically in the future. The ...
Do GLP-1 supplements work? What to know about ‘nature's Ozempic'
The products are being advertised as more affordable alternatives to blockbuster weight-loss drugs. Here’s what doctors think ...
CNN5d
GLP-1 pills are coming, and they could revolutionize weight-loss treatment
sold as Wegovy and Zepbound for weight loss (and for diabetes as the better-known Ozempic and Mounjaro). Dushay cited hopes that pill versions of GLP-1 drugs could ease shortages, come at lower ...
Weight-loss drug competition heats up with growing pill market
The weight-loss market is heating up as a number of companies are looking for a way to upend the dominance of market leaders Novo Nordisk ( NVO) and Eli Lilly ( LLY) by introducing GLP-1 pills.
STAT11d
Novo Nordisk’s amylin pill leads to substantial weight loss in early study
Novo Nordisk reported that its new obesity pill led to substantial weight loss in an early study, boosting the company’s ...
Novo Nordisk's experimental weight loss pill has some concerning side effects
Ozempic maker Novo Nordisk (NVO) announced mixed results today for a phase 2 trial of an experimental weight loss pill that ...